[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
作者信息
Ellard G A
出版信息
Cas Lek Cesk. 1984 Feb 10;123(6):158-64.
PMID:6697364
Abstract
摘要
相似文献
1
[The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].[异烟肼乙酰化酶表型在肺结核治疗中的潜在临床意义]
Cas Lek Cesk. 1984 Feb 10;123(6):158-64.
2
The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.比哈尔邦健康人群及肺结核患者中异烟肼乙酰化表型的发生率。
J Assoc Physicians India. 1978 May;26(5):353-60.
3
[Incidence of hepatic changes in relation to the isoniazid acetylator phenotype].[与异烟肼乙酰化表型相关的肝脏变化发生率]
Medicina (B Aires). 1980 Jul-Aug;40(4):382-6.
4
Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.接受异烟肼治疗的患者中使用磺胺二甲嘧啶进行乙酰化表型分析。
Int J Clin Pharmacol Res. 1984;4(2):141-4.
5
The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.异烟肼乙酰化代谢表型在肺结核治疗中的潜在临床意义。
Tubercle. 1984 Sep;65(3):211-27. doi: 10.1016/0041-3879(84)90079-5.
6
Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.肺结核患者血清与尿液中磺胺二甲嘧啶乙酰化作为异烟肼乙酰化状态预测指标的比较
Indian J Chest Dis Allied Sci. 1996 Jan-Mar;38(1):5-11.
7
[Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1981 Dec;4(6):349-51.
8
9
10
Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.三千名南印度患者在接受异烟肼治疗结核病期间，肝毒性与乙酰化代谢表型之间不存在相关性。
Am Rev Respir Dis. 1984 Jan;129(1):58-61. doi: 10.1164/arrd.1984.129.1.58.
Zotero 插件